Latest Asx Listing News

Pinnacle Minerals has begun trading on the U.S. OTCQB market under ticker PIMLF, enhancing access for American investors and supporting its strategic growth in critical minerals projects across Idaho and Washington.

Austral Gold has received TSX Venture Exchange approval to issue 1,025,077 shares as repayment of accrued interest on convertible notes, following a recent principal conversion. This move reflects ongoing capital management efforts amid the company’s growth strategy.

Infini Resources Limited’s I88OA securities have been suspended from ASX quotation due to non-compliance with listing rules, raising questions about the company’s regulatory standing.

Belararox Ltd announces the immediate resignation of founding Managing Director Arvind Misra, with Chairman Neil Warburton stepping in as interim leader during the search for a new executive director.

Atomic Eagle Ltd, formerly known as Tombador Iron Limited, will have its trading suspension lifted and be reinstated to quotation on the ASX starting 24 November 2025 after meeting key compliance requirements.

Aurumin Limited’s shares will be suspended from trading following court approval of Brightstar Resources’ acquisition scheme, marking a pivotal step in the takeover process.

Critica Limited has completed the first tranche of its $8 million placement, issuing over 203 million shares to accelerate development at its Jupiter rare earths project. The second tranche awaits shareholder approval in January 2026.

Rox Resources has successfully completed the first tranche of a $200 million capital raise, issuing 188.7 million shares at 35 cents each. The second tranche, worth $134 million, awaits shareholder approval in December.

Anson Resources has raised A$14 million through a well-supported placement to advance its lithium and uranium projects in Utah, signaling strong investor confidence in its development strategy.

Lodestar Minerals has responded to ASX queries clarifying the timing and disclosure of key assay results from its Ned’s Creek gold project and detailed the procedural steps behind its Arizona Mountain Pass rare earths acquisition.

Lynch Group Holdings shareholders have overwhelmingly approved a $269 million acquisition scheme by Hasfarm, offering a 23% premium on recent share prices. The deal awaits final court approval before completion in December 2025.

Alterity Therapeutics announces significant board changes, including the retirement of founding chairman Geoffrey Kempler and appointment of CEO Dr David Stamler as Managing Director, aligning leadership with its Phase 3 clinical ambitions.